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There is a clear-cut incremental value associated with the 
assessment of regional myocardial b ood flow and coronary 
reserve in a quantitativ‘ noninvasive manner (I). Such 
measurements are highly relevant for both understanding 
disease mechanisms and assessing diagnostic efficacy. 
Positron emission tomography and regional myocardial 
b flow. Potentially, positron emission tomography may 
be the optimal method for assessing and quantifying regional 
myocardial blood flow and coronary reserve of specific 
coronary vascular beds. The tomographic ability of the 
technique coupled with an improving resolution may even- 
tually enable assessment of endocardial versus epicardial 
perfusion. This has substantial pathophysiologic relevance 
because the endocardial region is the major site of the 
ischemic process. The positron emitting isotopes are gener- 
ally short-lived (several minutes) and thereby permit unen- 
cumbered, rapid sequential measurement of basal and post- 
interventional coronary reserve. The single photon emitting 
tracers are limited with respect o absolute stimates of 
regional blood flow because of inadequate correction for 
attenuation; nosuch limitation exists with positron emission 
tomography (2). Absolute quantification f flow is important 
when dealing with issues concerning the true definitions of 
supply/demand imbalance as well as diagnostic issues asso- 
ciated with false negative r sults occurring inthe presence of
diffuse and balanced myocardial ischemia. 
There are various approaches to the evaluation of re- 
gional myocartiiai blood flow by positron emission tomog- 
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ditorial comments. Briefly, one approach involves 
the “microsphere model” (3,4). ith this appro 
positron emitting radioisotopes, u as gallium-~$ 
car&on- I I, attached to particulate m~crospbcres have been 
used to measure r gional blood 
this technique is clearly limite 
requires left hear1 cat ~teri~at~o~ for infusion 
spheres either into t left atrium or directly into 
coronary circulation. A second 
concept of the fractional distribu of an i~trave~o~s~y 
administered tracer (9,lO). The radiopharmace~t~c~s em- 
ployed for this type of analysis include the potassium ana- 
logues that have been the stalwarts of conventional single 
photon perfusion scintigraphy. These include thallium 
for single photon studies and isotopes of rubidium 
potassium for positron emission tomography studies. Nitro- 
gen-13-labeled ammonia is also inchrded in this category. 
This model is attractive because it requires a single intrave- 
nous injection of the tracer for each study. 
tification of regional myocardial b ood flow 
and nitrogen-13 ammonia ssomewhat controversial (1 L-15). 
The first pass extraction ofthese tracers may also be affected 
by the metabolic status of the myocardium (1?!,16). 
A final approach for me~s~reme~6 oj rnyocar~~~~ blood 
fiow with positron emission tomography, and that used in the 
present study (171, employs diffusible tracers. Oxygen-1% 
labeled water is a freely diffusible tracer that is completely 
extractable and retained in the myocardium after first pass 
transit hrough the coronary circulation (18). In addition, its 
uptake does not vary with flow rate, and is relatively 
independent of the metabolic state of the myocardium. This 
latter property is particularly pertinent to clinical presenta- 
tions of prolonged ischemfa or reperfusion, orboth (19-22). 
Nonetheless, this technique has its unique limitations. The 
blood pool must be labeled with an additional tracer, oxy- 
gen-15 carbon monoxide, administered by inhalation after 
each study, to correct for the contaminating effects of 
intravascular tracer present in perfusion images (18). The 
low counting statistics after blood pool subtraction result in 
images that are not as “smooth” as those observed with, 
ammonia or rubidium-82. However, these limitations 
reasonable when one considers that quantification f 
requires meticulous determination f correction for blood 
pool, cardiac motion and partial volume effects, as well as 
accurate determination f the arterial input function (27). 
The present study. The present study by 
employs ingle vessel percutaneous transluminal coronary 
angioplasty asan appropriate simple clinical circumstance in 
which the utility of a quantitative positron emission tomog- 
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tlbction of rece 
coronary blood flow in 
relation. Long-term follow-up may be related irectly to the 
degree of cardiovascular reserve before and after successful 
interventional therapy. T to measure absolute 
as other types of heart disease. 
sugh the cost of establishing and operating a positron 
I. Gould KL. Lipscomb K. amilton GW. Physiologic basis for assessing 
2. 
3. 
4. 
5. 
6. 
7. 
8. 
9. 
10. 
II. 
I!. 
13. 
14. 
IS. 
16. 
critical coronary stenosis. Am J Cardiol 197&33:$5-94. 
Bergmann SR. Fox KAA. Geltman EG. Sobel BE. ‘Positron aC&m 
tomography 0 heart. Prog Cardiovasc’ Dis 1985;28: 165-94. 
Wagner MN. A. Sasaki Y. Ryan JP. Studies of the circulation 
with radioacti pheres. lnvesl Radio1 1969:4:374-86. 
deymann MA. Payne BD. Ho an J1E. Rudolph UA. Blood Wow 
measurements with ra~~o~~c~~~e-~abe~ed particles. Prog Cardiovasc Dis 
1977;2Q:55-18. 
Belier GA. Ahon WJ. Co&vi S. Hnatowich D. Assessment of regional 
mvocardial perfusion by positron emission tomography after iatracoro- 
nary administration of gallium-68 labeled albumin microsphe~;s. 9 Com- 
put Assist Tomogh 1979:3:447-52. 
Nichols AB. Moore RH. Cochavi S. Pohort GM. Strauss W 
cation of myocardial infarction by comyllter-assisted positron emission 
tomography. Cardiovasc Res 1980;34:423-34. 
Wisenberg 6. Schelbert H n EI. c? al. In vivo quant~tal~on of 
regional myocardial blood silron emission tomography. Circu- 
lation 1981:63:1248-58. 
Wilson IRA. Shea MJ. DeLandsheere CM. et al. Validation of 
of regional myocardial blood ow in vivo with C-11 labeled human 
albumin microspheres and positron emission tomography. Circulation 
1984:70:717-23. 
Sapirstein LA. Fractionation of the cardiac output of rats with isotopic 
potassium. Circ Res ~956:4:6$9-92. 
Sapirstein LA. Regional blood Row by fractional distribution of indica- 
tors. Am J Physiol 1958:193:161-8. 
Love WD. Burch GE. influence of the rate of coronary plasma flow on the 
extraction of Rb-86 from coronary blood. Circ Res 1959:7:24-30. 
Moir TW. Measurement of coronary blood flow in dogs with normal and 
abnormal myocardial oxygenation and function. Circ Res 1966;191695-9. 
Bergmann SR. Hack S. Tewson T. Welch MJ. Sobell BE. The depen- 
dence of accumulation of “NH3 by myocardium on metabolic factors and 
its implications for quantitative assessment of perfusion. Circulation 
1980:61:34-43. 
uang SC. Phelps ME. MacDonald NS. Shin& 1. 
of 13NtfJ myocardial extraction and clearance on Pow and 
Am J Physiol 1982:242:W536-42. 
Knoebel SB. Lowe DK. Lovelace DE. Friedman JJ. 
Row as measured by fractional uptake of rubidium-82 and microspheres. 
J Nucl Med 1978;91:1020-6. 
Fukuvama T. Nakamura M, Naltagaki 0. Matsuguchi H. Mitsutake A. 
Keduced reflow and diminished uptake of “Rb after temporary coronary 
occlusion. Am J Physio! 1978;234:H724-9. 
130 SOUFERANDZARET 
EDITORIALCOMMENT 
17. Walsh MN, Geltman EM, Steele RL. et al. Augmented myocardial 
perfusion reserve after coronary angioplasty quantified by positron emis- 
sion tomography with Hr”O. J Am Coil Cardiol 1990;15: 119-27. 
18. Walsh MN, Bergmann SR. Steele RL. et al. Delineation of impaired 
regional myocardial perfusion by positron emission tomography with 
H IsO Circulation 1988*7&612-20 2 . 9. . 
19. Bergmann SR. Fox KAA, Rand AL, et al. Quantification of regional 
myocardial blood flow in vivo with H2150. Circulation 1984;70:724-33. 
20. Huang SC, Schwaier M, Carson RE, et al. Quantitative measurement of 
myocardial blood flow with oxygen-IS water and positron computed 
tomography: an assessment of potential problems. J Nucl bled 1985:26: 
616-25. 
21. Knabb RB, Fox KAA. Sober BE, Bergmann SR. Characterization of the 
functional significance of subcritical coronary stenoses with HaiS and 
positron emission tomography. Circulation 1985;71:1271-8. 
22. 
23. 
24. 
25. 
JACC Vol. l5,No. I 
January 1 :128-30 
Knabb RM, Rosamond TL, Fox #AA, Sobel 
hancement of salvage of reperfused ischemic myocardittm by diltiaxem. 
J Am Coil Cardioi 1986;8:861-71. 
White CW, Wright CB, Doty DB, et al. Does visual interpretation of the 
coronary arteriogram predict the physiologic importance of a coronary 
stenosis? N Engl J Med 1984;310:819-24. 
Roxanski A, Bairey CN, Krantz DS. et al. Mental stress and the induction 
of silent myocardial ischemio in patients with coronary artery disease. 
N Engl J Med 1988;318:19&12. 
Schelbert HR, Buxton D. Insights into coronary artery disease &ned 
from metabolic imaging. Circulation 1988:78:4%-505. 
26. Gould KL. Goldstein RA. conomic analysis of clinical 
positron emission tomography of the heart with rubidium-82. J Nucl 
1989;30:707-17. 
